Anixa biosciences stock.

Complete Anixa Biosciences Inc. stock information by Barron's. View real-time ANIX stock price and news, along with industry-best analysis. Zacks Equity Research. Anixa Biosciences, Inc. ANIX was a big mover last session, as the company saw its shares rise nearly 9% on the day. The move came on solid volume too with far more shares ...Phone Number 6315495974. Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer ...Stock Price Forecast. According to 2 stock analysts, the average 12-month stock price forecast for ANIX stock stock is $10.5, which predicts an increase of 210.65%. The lowest target is $9.00 and the highest is $12. On average, analysts rate ANIX stock stock as a strong buy.Anixa Biosciences Announces $10 Million Bought Deal Offering of Common Stock. News provided by. Anixa Biosciences, Inc. 22 Mar, 2021, 17:18 ET. SAN JOSE, Calif., March 22, 2021 /PRNewswire ...

SAN JOSE, Calif., Oct. 3, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value.

Stock analysis for Anixa Biosciences Inc (ITUS:US) including stock price, stock chart, company news, key statistics, fundamentals and company profile.View the latest Anixa Biosciences Inc. (ANIX) stock price, news, historical charts, analyst ratings and financial information from WSJ.

August 07, 2023. SAN JOSE, Calif., Aug. 7, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has begun enrolling subjects in a treatment arm evaluating the combination of the ...Anixa Biosciences Inc stock performance at a glance. Check Anixa Biosciences Inc’s past financial performance, like revenue or net income, plus the top level summary of its past and current market value. In depth view into ANIX (Anixa Biosciences) stock including the latest price, news, dividend history, earnings information and financials.What Makes ANIXA BIOSCIENCES INC (ANIX) a New Buy Stock finance.yahoo.com - June 22 at 3:50 PM. benzinga.com logo · Anixa Biosciences Stock (NASDAQ:ANIX), ...

Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic ...

Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. Anixa's therapeutic portfolio consists of an ovarian cancer immunotherapy program being developed in collaboration with Moffitt Cancer Center, which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology.

Nov 20, 2023 · Anixa Biosciences Inc’s trailing 12-month revenue is $0.2 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.320 per share for the current fiscal year. Anixa Biosciences Inc does not currently pay a dividend. Company to present on its ongoing Phase 1 ovarian cancer CAR-T trial. SAN JOSE, Calif., Oct. 31, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that it will present at the Ovarian Cancer National …Anixa Biosciences stock has received a consensus rating of buy. The average rating score is and is based on 12 buy ratings, 0 hold ratings, and 0 sell ratings. What was the 52-week low for Anixa ...Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others.Anixa Biosciences, Inc. Stock price Equities ANIX US03528H1095 Biotechnology & Medical Research Summary Quotes Charts News Ratings Calendar Company Financials …

Oct 23, 2023. Anixa Biosciences Appoints Accomplished Medical Oncologist and Biotechnology Executive, Dr. Mark A. Goldberg, to Cancer Business Advisory BoardTrack Anixa Biosciences Inc (ANIX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get valuable insights from the community of like minded traders and investors Last Funding Type Grant; Also Known As ITUS Corporation; Legal Name CopyTele, Inc. Stock Symbol NASDAQ:ANIX; Company Type For Profit. Phone Number 6315495974.Anixa Biosciences, Inc. Analyst Report: Moderna, Inc. Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA ...SAN JOSE - Anixa Biosciences, Inc. ('Anixa' or the 'Company') (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has begun enrolling subjects in a treatment arm evaluating the combination of the Company's breast cancer vaccine with Keytruda (pembrolizumab).

View ANIX: Anixa Biosciencesinvestment & stock information. Get the latest ANIX: Anixa Biosciences detailed stock quotes, stock data, Real-Time ECN, charts, stats and more..What is the Anixa Biosciences stock forecast? · Anixa Biosciences stock prediction for 1 year from now: $ 2.33 (-28.80%) · Anixa Biosciences stock forecast for ...

18 Okt 2023 ... Anixa Biosciences; A Brief Investor Q&A With CEO and Chairman Amit Kumar, PhD. 3 views · 5 minutes ago ...more ...Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others.Dec 8, 2022 · SAN JOSE, Calif., Dec. 8, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ... Mar 22, 2023 · Chardan Capital analyst Matthew Barcus maintained a Buy rating on Anixa Biosciences (ANIX – Research Report) today and set a price target of $9.00. The company’s shares opened today at $4.12 ... Anixa Biosciences And 2 Other Penny Stocks Insiders Are Aggressively Buying benzinga.com - July 24 at 8:26 AM: Vir Biotechnology (VIR) Down on Influenza Study Failure finance.yahoo.com - July 21 at 2:49 PM: Insider Buying: Anixa Biosciences, Inc. (NASDAQ:ANIX) CFO Buys 5,500 Shares of Stock marketbeat.com - July 21 at …Anixa Biosciences, Inc. is estimated to report earnings on 03/10/2023. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks ...Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that, in partnership with Moffitt ...SAN JOSE, Calif. and STUTTGART, Germany, Jan. 24, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and ...Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others.Aug 7, 2023 · SAN JOSE, Calif., Aug. 7, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...

Anixa's therapeutics portfolio consists of a cancer immunotherapy program which uses a novel type of CAR-T, known as chimeric endocrine receptor T-cell (CER-T) technology. Anixa’s vaccine portfolio consists of technology focused on the immunization against specific “retired” proteins associated with breast cancer, specifically triple ...

Track Anixa Biosciences Inc (ANIX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get ...

Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others.ANIXA BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Earnings for Anixa Biosciences are expected to decrease in the coming year, from ($0.32) to ($0.37) per share. Anixa Biosciences has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Wednesday, January 3rd, 2024 based off prior year's report dates. Read More.SAN JOSE, Calif., Oct. 3, 2023 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today ...Anixa Biosciences, Inc. 3150 Almaden Expressway. Suite 250 San Jose, CA 95118 408-708-9808 [email protected] BIOSCIENCES INC (ANIX) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others.Discover Anixa Biosciences' earnings and revenue growth rates, forecasts, and the latest analyst predictions while comparing them to its industry peers. ... Lead Independent Director exercised options to buy US$119k worth of stock. Aug 02. Press Release: Anixa Biosciences Announces Notice of Allowance of Additional Patent on …According to 1 Wall Street analyst that have issued a 1 year ANIX price target, the average ANIX price target is $12.00, with the highest ANIX stock price ...Anixa Biosciences Inc’s trailing 12-month revenue is $0.2 million with a % profit margin. Year-over-year quarterly sales growth most recently was %. Analysts expect adjusted earnings to reach $-0.320 per share for the current fiscal year. Anixa Biosciences Inc does not currently pay a dividend.

The following insiders have purchased ANIX shares in the last 24 months: Amit Kumar ($69,540.00), Lewis H Titterton Jr ($155,021.44), and Michael Catelani ($26,367.77). How much insider buying is happening at Anixa Biosciences? Insiders have purchased a total of 71,253 ANIX shares in the last 24 months for a total of $250,929.21 …Track Anixa Biosciences Inc (ANIX) Stock Price, Quote, latest community messages, chart, news and other stock related information. Share your ideas and get ...Oct 31, 2023 · Anixa Biosciences plunges on upsizing stock offering to $22.5M SA News Tue, Mar. 23, 2021 2 Comments. Anixa Biosciences to raise $10M in bought deal offering SA News Mon, Mar. 22, 2021 1 Comment. Anixa Biosciences (Nasdaq:ANIX) - Stock Price, News & Analysis - Simply Wall St Stocks / Pharmaceuticals & Biotech Anixa Biosciences NasdaqCM:ANIX …Instagram:https://instagram. eem stock priceasset based refinancetriple flag precious metalsscott trade login SAN JOSE, Calif., Dec. 8, 2022 /PRNewswire/ -- Anixa Biosciences, Inc. (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer and infectious diseases, today ... instant debit cardbest forex traders in usa Oct 13, 2023 · The cell therapy being evaluated in Anixa's Phase 1 study differs from traditional CAR-T therapy in that it targets the FSHR, which research indicates is exclusively expressed on ovarian cells in healthy adult females. About Anixa Biosciences, Inc. Anixa is a clinical-stage biotechnology company focused on the treatment and prevention of cancer. private social clubs Nov 27, 2023 · Anixa Biosciences, Inc. is a biotechnology company. The Company is primarily engaged in developing vaccines and therapies that are focused on critical unmet needs in oncology and infectious disease. The Company's segments include CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics and Others. SAN JOSE - Anixa Biosciences, Inc. ('Anixa' or the 'Company') (NASDAQ: ANIX), a biotechnology company focused on the treatment and prevention of cancer, today announced that its partner, Cleveland Clinic, has begun enrolling subjects in a treatment arm evaluating the combination of the Company's breast cancer vaccine with Keytruda (pembrolizumab).Phone Number 6315495974. Anixa is a publicly-traded biotechnology company focused on harnessing the body's immune system in the fight against cancer. Anixa's therapeutic portfolio includes a cancer vaccine technology focused on the immunization against α-Lactalbumin to prevent triple negative breast cancer (TNBC), as well as a cancer ...